Indivior faces huge sales loss as Suboxone court loss puts generics on tap next week

Indivior has been fighting off generics to its top-selling Suboxone film, but a federal appeals court has unleashed copycats now charging toward launches next week. And that means hundreds of millions in lost sales for a company that's hurting for sales from follow-up drugs.